Lars Erik Bryld
Clinical Associate Professor
1 - 1 out of 1Page size: 10
- 2018
- Published
Safety, efficacy and drug survival of biologics and biosimilars for moderate-to-severe plaque psoriasis
Egeberg, A., Ottosen, M. B., Gniadecki, R., Broesby-Olsen, S., Dam, T. N., Bryld, Lars Erik, Rasmussen, M. K. & Skov, Lone, 2018, In: British Journal of Dermatology. 178, 2, p. 509-519 11 p.Research output: Contribution to journal › Journal article › Research › peer-review
ID: 32369880
Most downloads
-
77
downloads
Patient-reported Outcomes During Treatment in Patients with Moderate-to-severe Psoriasis: A Danish Nationwide Study
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
18
downloads
Response to biologics during the first six months of therapy in biologic-naïve patients with psoriasis predicts risk of disease flares: A danish nationwide study
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
11
downloads
Trajectories and prognosis after discontinuation of biologics due to remission in psoriasis: A nationwide cohort study
Research output: Contribution to journal › Comment/debate › Research › peer-review
Published